Ascend Hires Scott Law as COO and Continues Strengthening Foundation
LONDON, April 24, 2024 /PRNewswire/ -- Ascend Advanced Therapies (Ascend), an end-to-end gene therapy development partner, has announced the addition of industry veteran Scott Law as Chief Operations Officer (COO).
- LONDON, April 24, 2024 /PRNewswire/ -- Ascend Advanced Therapies (Ascend), an end-to-end gene therapy development partner, has announced the addition of industry veteran Scott Law as Chief Operations Officer (COO).
- Scott brings more than 30 years of global pharmaceutical experience, including senior manufacturing roles at companies such as Telix Pharmaceuticals, Baxter, Emergent BioSolutions, Ferndale Laboratories, and Pfizer.
- The addition of Scott further elevates our depth of talent in this market, which is a key differentiator and mainstay of the foundation at Ascend."
- We also must have the right level of expertise and execution to continue growing our position as the leading AAV CDMO," new COO, Scott Law offered.